From PCOS to PEMOS: The bigger health picture
Polycystic ovarian syndrome (PCOS) has been around as a term for 40-50 years. But now, it has a new name—polyendocrine metabolic ovarian syndrome (PEMOS)—that describes the issue better.
Both men and women can get PEMOS. The name change has brought new awareness to the disorder and who it can affect.
Dental professionals are in a unique position to help patients get the care they need. How can we start a conversation with our patients?
Join us in Medical History Mysteries as we talk about PEMOS in its broader scope and how it may affect dental treatment.
Thumbnail image credit: EmirMemedovski / E+ via Getty Images
More Medical History Mysteries videos …
The Dental Economics Network brings you the best content from Dental Economics, RDH, DentistryIQ, and Perio-Implant Advisory.
Editor’s note: This article first appeared in Clinical Insights newsletter, a publication of the Endeavor Business Media Dental Group. Read more articles and subscribe.
About the Author
Pamela Maragliano, DMD
Pamela Maragliano, DMD, is the chief editor of Dental Economics. Based in Salem, Massachusetts, Dr. Maragliano began her clinical career as a dental hygienist. She went on to attend Tufts University School of Dental Medicine, where she earned her doctorate in dental medicine. She then attended the University of California, Los Angeles, School of Dental Medicine, where she became board-certified in prosthodontics. Dr. Maragliano owns a private practice, Salem Dental Arts, and lectures on a variety of clinical topics. You may contact her at [email protected].
Tom Viola, RPh, CCP
With more than 30 years’ experience as a board-certified pharmacist, clinical educator, professional speaker, and published author, Tom Viola, RPh, CCP, has earned the reputation as the go-to specialist for making pharmacology practical and useful for dental teams. He is the founder of Pharmacology Declassified and is a member of the faculty of more than 10 dental professional degree programs. Viola has contributed to several professional journals and pharmacology textbooks, and currently serves as a consultant to the American Dental Association’s Council on Scientific Affairs.